STAT

Her son died. Two decades later, she met the medical student who got his heart

The young man handed her a stethoscope, opened his shirt, and pointed to where she should place it. Hesitantly, she reached forward, pressed it to his skin, and broke into tears.

The heart Elisabeth Tilly heard inside the chest of a 25-year-old stranger was the same that once beat inside her son. Christopher, age 8, was killed more than two decades ago, by a truck barreling through a crosswalk in front of his elementary school. But the memory of her grievously injured son lying in a Salt Lake City hospital is still raw.

A few doors down from Christopher, 4-year-old Jon Hochstein was fighting for his life. His heart had enlarged, damaged beyond repair, perhaps by a passing virus, or just bad luck. His family wasn’t sure he would make it through the night.

Tilly didn’t want to donate Christopher’s organs. He’d need them in heaven, she thought. But then she saw Hochstein’s tiny legs poking out from under the sheets.

She decided that this little boy needed Christopher’s heart more than he did.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks